RESUMEN

Hypoxic ischemic encephalopathy (HIE) is the most common cause of neonatal encephalopathy and results in significant morbidity and mortality. Long-term outcomes of the condition encompass impairments across all developmental domains. While therapeutic hypothermia (TH) has improved outcomes for term and late preterm infants with moderate to severe HIE, trials are ongoing to investigate the use of TH for infants with mild or preterm HIE. There is no evidence that adjuvant therapies in combination with TH improve long-term outcomes. Numerous trials of various adjuvant therapies are underway in the quest to further improve outcomes for infants with HIE.

Asunto(s)

Hipotermia Inducida , Hipoxia-Isquemia Encefálica , Recien Nacido Prematuro , Humanos , Hipoxia-Isquemia Encefálica/terapia , Recién Nacido , Hipotermia Inducida/métodos , Resultado del Tratamiento